Financial Data and Key Metrics Changes - Net sales for Q2 2025 were $16.1 million, a 38% decrease from $25.8 million in Q2 2024 [13] - Gross profit for Q2 2025 was $2.5 million, a 45% decrease from $4.6 million in Q2 2024 [14] - Net loss for Q2 2025 was $1.5 million, compared to a net income of $0.3 million in Q2 2024 [14] - Cash and cash equivalents increased to $18.4 million from $17.3 million at the end of Q1 2025, driven by $1.8 million in cash flow from operations [15] Business Line Data and Key Metrics Changes - The company has signed several long-term contracts with new and existing customers, with over 80 customers now under long-term agreements [8] - A new product purchase agreement was established with Innovative Renal Care, representing a multimillion-dollar commitment over three years [9][10] Market Data and Key Metrics Changes - The company remains a leading supplier in the hemodialysis concentrates market, serving over 12,000 purchasing facilities in the U.S. and select international markets [7] - The transition of the largest customer to another supplier has significantly impacted sales, but the company is working to stabilize and grow its customer base [5][11] Company Strategy and Development Direction - The company aims to secure its base business with long-term contracts and fill revenue gaps caused by customer transitions [5] - Focus on capital investment in equipment to enhance manufacturing efficiency and reduce costs [26] Management's Comments on Operating Environment and Future Outlook - Management believes the company is well-positioned for growth in the latter half of the year despite current challenges [6] - Discussions with the largest customer, DaVita, are ongoing for a long-term supply agreement, which could positively impact future revenues [22][23] Other Important Information - The company has reduced customer concentration risk, with the largest customer now accounting for only 10% of revenue, down from 40-45% [37] - The company is focused on creating a reliable and reproducible business model to ensure consistent performance and cash flow [28][29] Q&A Session Summary Question: Expansion plans in the Western United States - Management sees significant opportunities in the West, with a potential market of approximately $100 million, and is working on acquiring larger customers [19][20] Question: Negotiations with the largest customer - Ongoing discussions with DaVita aim to establish a long-term supply arrangement, which could impact financials positively towards the end of the year [22][23] Question: Capital allocation priorities - Current focus is on investing in capital equipment to enhance manufacturing efficiency, while ensuring sufficient resources for debt obligations [26] Question: Gross margin stability despite revenue decline - The organization has been right-sized, and investments in new equipment have improved efficiency, helping to maintain gross margins [33][34] Question: Customer concentration risk mitigation - The company has successfully diversified its customer base, significantly reducing concentration risk [37][38] Question: Impact of competitor's product recall - The company is working closely with customers to supplement supply due to issues faced by a competitor, which has created opportunities for Rockwell [41][42]

Leadership Changes - Alex Macdonald has been appointed as Chief Executive Officer, effective July 6, 2025, succeeding Adrian Montgomery [1][2] - J.B. Elliott has been appointed as President and Chief Operating Officer, previously serving as Chief Strategy Officer and General Counsel [3] - Nathan Teal has been appointed as Interim Chief Financial Officer, bringing over 20 years of experience in public accounting and financial reporting [4] Business Strategy and Divestment - The company has signed a letter of intent (LOI) with an entity controlled by Adrian Montgomery for the divestment of its direct sales business line and related creative assets [5] - The direct sales business includes Omnia Media Inc. and GameCo Esports Canada Inc., which hold the company's YouTube CSP licenses and esports operations, respectively [5] - Following the transaction, the company will retain its owned and operated content channels, ensuring continuity in operations [6] Financial Implications - The proposed transaction includes a purchase price of US$1,000,000, with the purchaser assuming certain liabilities related to the acquired entities [7][8] - The transaction is expected to result in approximately $10 million of annual cost savings, leading to material improvements in Adjusted EBITDA and significant working capital benefits [11] Future Business Focus - Post-transaction, the company will continue to operate its portfolio of owned and operated digital assets, including major gaming properties and events [12] - The company aims to deepen direct engagement with its audience and expand its owned intellectual property, focusing on monetizing more effectively [13][14]

Core Insights - Advisors are actively seeking strategies to refine and future-proof their practices, with 40% considering significant business transitions within the next 18 months [1][4][5] - The financial advisory industry is undergoing profound transformation due to evolving client expectations, technological advancements, and demographic shifts [3][4] Business Transition and Planning - 40% of financial advisors are contemplating selling their practices, merging with other firms, or making key changes in strategic partnerships [1] - Succession and continuity planning are top concerns for advisors, emphasizing the need for structured exit strategies [1][4] Operational Focus - 92% of advisors prioritize expanding their businesses, with 80% identifying business planning as a top priority [8] - 51% of advisors cite operational efficiency as crucial for strengthening their firm's foundation for scalable growth [8] - 43% are investing in people and culture to enhance talent acquisition, retention, and long-term team development [8] SEI's Business Audit Tool - SEI's business audit tool provides personalized insights into business health and areas of opportunity for advisors [2] - The tool helps advisors assess key areas of their businesses and strategically prioritize next steps [3]

Financial Data and Key Metrics Changes - For the full year of 2024, the company generated net sales of $101,500,000, representing a 21% increase over net sales of $83,600,000 for 2023 [5][22] - Gross margin for the full year 2024 was 17%, an improvement from 10% in 2023 [23] - Adjusted EBITDA for the full year 2024 was a positive $5,200,000, representing a $9,000,000 improvement over a negative adjusted EBITDA of $3,900,000 in 2023 [25] Business Line Data and Key Metrics Changes - Net product sales for the full year 2024 were $101,400,000, a 27% increase over 2023, driven by new customers from the Evoqua acquisition and a large order from the largest customer [22] - Gross profit for Q4 2024 was $3,600,000, a 27% increase over Q4 2023 [23] Market Data and Key Metrics Changes - The company has expanded its distribution agreement with Nephro Group Dialysis Centers in the Philippines, becoming the exclusive supplier of all dry hemodialysis concentrate products [16] - International sales continue to grow, with products sold in over 30 countries [16] Company Strategy and Development Direction - The company aims to diversify its customer base and product portfolio while optimizing its business operations [10][72] - Plans for 2025 include targeting additional customers representing an estimated 14,500,000 gallons of potential business [19] Management's Comments on Operating Environment and Future Outlook - Management views 2025 as a transition year but aims to return to growth within the same year [36] - The transition away from the largest customer is expected to result in a loss of approximately $34,000,000 in revenue compared to 2024 [8] Other Important Information - The company terminated its agreement with a third-party contract manufacturer, which will save over $2,000,000 annually in fixed overhead costs [9][24] - Cash, cash equivalents, and investments at the end of 2024 were $21,600,000, an increase from $10,900,000 at the end of 2023 [26] Q&A Session Summary Question: Revenue from the largest customer in 2025 - The largest customer historically generated around $45,000,000, and the expected decline of $34,000,000 is a good way to think about the revenue guidance for 2025 [30][31] Question: Transition year and expense reductions - Management views 2025 as a transition year but aims for growth within the same year, with expense reductions being implemented to mirror the decline in volume [34][36] Question: Factors leading to the largest customer's pivot - The decision by the largest customer to diversify its supplier base was made prior to the current management's arrival, and there are no current issues with other customers [44][46] Question: Growth of the bicarbonate cartridge business - The strategy is to introduce the new bicarbonate cartridge product to the existing customer base, with expectations for short-term sales growth in 2025 [49] Question: Guidance assumptions and international expansion - The revenue guidance for 2025 assumes the largest customer will transition away completely, and any agreements reached would be upside to the guidance [54][56]

Financial Data and Key Metrics Changes - For the full year of 2024, the company generated net sales of $101,500,000, representing a 21% increase over net sales of $83,600,000 for 2023 [5][22] - Gross margin for the full year 2024 was 17%, an improvement from 10% in 2023 [23] - Adjusted EBITDA for the full year of 2024 was a positive $5,200,000, representing a $9,000,000 improvement over a negative adjusted EBITDA of $3,900,000 in 2023 [25] Business Line Data and Key Metrics Changes - Net product sales for the full year 2024 were $101,400,000, a 27% increase over 2023, driven by new customers from the Evoqua acquisition and a large order from the largest customer [22] - Gross profit for Q4 2024 was $3,600,000, a 27% increase over Q4 2023 [23] Market Data and Key Metrics Changes - The company has expanded its international sales, currently selling products in over 30 countries [17] - The single-use bicarbonate disposables market represents an approximate $100,000,000 opportunity, one of the fastest-growing segments within the dialysis products market [18] Company Strategy and Development Direction - The company aims to diversify its customer base and product portfolio while optimizing its business operations [10][72] - Plans for 2025 include targeting additional customers representing an estimated 14,500,000 gallons of potential business [20] Management's Comments on Operating Environment and Future Outlook - Management views 2025 as a transition year but aims to return to growth within the same year [36] - The transition away from the largest customer is expected to result in a loss of approximately $34,000,000 in revenue compared to 2024 [8] Other Important Information - The company terminated its agreement with a third-party contract manufacturer, which will save over $2,000,000 annually in fixed overhead costs [9][24] - Cash, cash equivalents, and investments at the end of 2024 were $21,600,000, an increase from $10,900,000 at the end of 2023 [26] Q&A Session Summary Question: Revenue from the largest customer in 2025 - The largest customer historically generated around $45,000,000, and with the expected transition, a loss of $34,000,000 is anticipated, leading to a revenue estimate of approximately $11,000,000 from this customer in 2025 [30][31] Question: Discussions with the largest customer - The transition is to diversify their supplier base, and discussions are ongoing regarding future volume commitments, which are not included in the current guidance [32][33] Question: Transition year and expense reductions - 2025 is viewed as a transition year, with plans to return to growth, and expense reductions will be implemented to align with the expected decline in volume [34][35] Question: Factors leading to the largest customer's decision - The decision to pivot away was made prior to the current management's arrival, and there are no current issues with other customers [44][46] Question: Growth strategy for the bicarbonate cartridge business - The strategy involves introducing the product to the existing customer base, with expectations for growth as customers switch to compatible machines [48][49] Question: Guidance and revenue offset strategies - The guidance for 2025 assumes the largest customer will transition away completely, and any successful negotiations would be considered upside to the guidance [54][56]